当前位置:首页 - 行情中心 - 恒瑞医药(600276) - 财务分析

恒瑞医药

(600276)

  

流通市值:2956.36亿  总市值:2958.58亿
流通股本:63.74亿   总股本:63.79亿

恒瑞医药(600276)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润34.51亿元,每股收益0.55元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益4020658.61万元,未分配利润2797436.11万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产4287139.07万元,负债266480.46万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入17,013,632,174.6111,168,379,006.135,492,320,140.4321,275,270,681.52
营业总成本13,258,786,705.298,728,806,054.534,206,402,335.2417,747,084,300.6
营业利润3,941,329,512.972,570,209,358.271,344,430,121.814,111,959,971.91
利润总额3,812,376,918.612,512,445,165.181,324,748,660.223,968,492,118.85
净利润3,451,029,827.762,290,405,823.551,233,392,458.393,815,070,903.04
其他综合收益14,004,359.1222,513,217.11-19,686,026.0215,868,800.02
综合收益总额3,465,034,186.882,312,919,040.661,213,706,432.373,830,939,703.06
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计30,628,112,709.0729,890,953,637.1730,650,444,105.1530,934,054,194.94
非流动资产合计12,243,278,032.4212,070,379,613.6911,643,385,891.0811,420,954,932.76
资产总计42,871,390,741.4941,961,333,250.8642,293,829,996.2342,355,009,127.7
流动负债合计2,445,150,681.652,259,969,029.042,536,712,807.163,639,219,602.64
非流动负债合计219,653,923.56265,499,169.34283,033,133.82302,633,381.89
负债合计2,664,804,605.212,525,468,198.382,819,745,940.983,941,852,984.53
归属于母公司股东权益合计39,636,900,593.9438,860,607,250.1938,891,810,104.9737,823,808,247.49
股东权益合计40,206,586,136.2839,435,865,052.4839,474,084,055.2538,413,156,143.17
负债和股东权益合计42,871,390,741.4941,961,333,250.8642,293,829,996.2342,355,009,127.7
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计16,456,269,933.1912,145,249,116.944,016,914,028.7519,555,010,992.69
经营活动现金流出小计12,147,398,752.279,269,900,647.573,802,944,748.0518,289,746,360.76
经营活动产生的现金流量净额4,308,871,180.922,875,348,469.37213,969,280.71,265,264,631.93
投资活动现金流入小计2,610,227,122.21,985,650,059.781,046,771,619.199,825,114,311.67
投资活动现金流出小计1,372,640,665.79987,443,010.78386,846,551.229,434,824,944.73
投资活动产生的现金流量净额1,237,586,456.41998,207,049659,925,067.97390,289,366.94
筹资活动现金流入小计21,100,00010,750,47010,000,0001,798,855,480.79
筹资活动现金流出小计3,111,042,990.322,632,565,941.661,474,800,965.462,117,625,690.24
筹资活动产生的现金流量净额-3,089,942,990.32-2,621,815,471.66-1,464,800,965.46-318,770,209.45
汇率变动对现金及现金等价物的影响19,695,828.827,703,481.52-10,038,953.680,497,370.18
现金及现金等价物净增加额2,476,210,475.811,279,443,528.23-600,945,570.391,417,281,159.6
期末现金及现金等价物余额17,013,647,723.8915,816,880,776.3113,936,491,677.6914,537,437,248.08
TOP↑